Copy Link Print Information

Dihydroartemisinin

(Synonyms: Dihydroqinghaosu; β-Dihydroartemisinin; Artenimol)
45 Cited Publications
고객리뷰

Based on 45 publication(s) in Google Scholar

Dihydroartemisinin is an orally active metabolite of rtemisinin (HY-B0094) and antimalarial agent. Dihydroartemisinin induces Autophagy by inhibiting NF-κB activation. Dihydroartemisinin promotes ROS accumulation. Dihydroartemisinin exhibits anticancer activity in esophageal cancer cells. Dihydroartemisinin shows schistosomicidal activity against juvenile and adult worms of Schistosoma japonicum, reduces worm burden, and displays antiparasitic activity. Dihydroartemisinin can be used in research related to multiple myeloma, promyelocytic leukemia, esophageal cancer, and Schistosoma japonicum infection.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity : 98.0%
  • CAS No.: 71939-50-9
  • 화학식: C15H24O5
  • 분자량:284.35
  • 보관:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Dihydroartemisinin Chemical Structure
    Dihydroartemisinin Chemical Structure
  • Experimental Validation Results for Dihydroartemisinin
  • Experimental Validation Results for Dihydroartemisinin
  • Experimental Validation Results for Dihydroartemisinin
  • Experimental Validation Results for Dihydroartemisinin
CAS No.: 71939-50-9
사이즈
가격
재고
수량
Amount: USD 0.00
Please select quantity
or
or

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Dihydroartemisinin:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
주변의 대리점 찾기 Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Dihydroartemisinin

More
Customer Validation & Images
WBCell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay
  • WB
  • Cell Proliferation/Viability Assay
  • WB

All Parasite Isoforms

More

All NF-κB Isoforms

More

Keywords

MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress 로그인
Register
Sign in to MedChemExpress
회원가입

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Dihydroartemisinin Chemical Structure
    Dihydroartemisinin Chemical Structure
    1/16
  • 1/16

    Dihydroartemisinin purchased from MedChemExpress. Usage Cited in: Kaohsiung J Med Sci. 2023 Jul;39(7):699-709. [Abstract]

    Customer Validation
     Dihydroartemisinin (DHA; 12.5, 25, 50 μM; 24 h) significantly reduces the viability of A549-GR cells in a dose-dependent manner.

  • 1/16

    Dihydroartemisinin purchased from MedChemExpress. Usage Cited in: Kaohsiung J Med Sci. 2023 Jul;39(7):699-709. [Abstract]

    Customer Validation
     Dihydroartemisinin (DHA; 12.5, 25, 50 μM; 24 h) increases the expression of cleaved-Caspase 3, but decreases the expression of PARP and Bcl-2 in A549-GR cells.

  • 1/16

    Dihydroartemisinin purchased from MedChemExpress. Usage Cited in: Oxid Med Cell Longev. 2023 Feb 16:2023:9595201. [Abstract]

    Customer Validation
     Dihydroartemisinin (DHA; 50, 100 µM) remarkably inhibits single-cell colony formation of HSC3 cells and SAS cells in a dosage-dependent manner (Fig e and f).

  • 1/16

    Dihydroartemisinin purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2018 Jun 27;501(3):636-642. [Abstract]

    Customer Validation
     Immunoblot analysis of the expression levels of BCL-2 and BAX after treatment of HCT116 TP53-/- cells with 20 μM 5-FU and 1.25 μM DHA alone or in combination for 48 h. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a loading control.

  • Dihydroartemisinin